Kate Quackenbush

Director of Communications at NATTOPHARMA ASA - Høvik, , NO

Kate Quackenbush's Colleagues at NATTOPHARMA ASA

Senior Vice President of Global Sales and Marketing

Contact

Rudi Man

Vice President Sales Europe & Asia

Contact Rudi Man

William Sommer

senior vice president, global development and regulatory

Contact William Sommer

Kathe Bleken

Senior Vice President Sales and Marketing

Contact Kathe Bleken

Eric Anderson

SVP New Business Development NattoPharma AS

Contact Eric Anderson

Hind Aidem

Financial Controller

Contact Hind Aidem

View All Kate Quackenbush's Colleagues
Kate Quackenbush's Contact Details
HQ
Location
Edison, New Jersey, United States
Company
NATTOPHARMA ASA
Kate Quackenbush's Company Details
NATTOPHARMA ASA logo, NATTOPHARMA ASA contact details

NATTOPHARMA ASA

Høvik, , NO • 20 - 49 Employees
BioTech/Drugs

Vitamin K2 is now recognized as an essential ingredient for aging healthily. This understanding stems from the substantial body of clinical evidence confirming the bone and cardiovascular health benefits of Vitamin K2 as MK-7 started by NattoPharma and is now being perpetuated by Gnosis by Lesaffre.Securing and maintaining our bone and cardiovascular health are two of the most significant areas impacting our ability to age well. Both areas are impacted by the way our bodies utilize calcium. Ideally, calcium would bind to the bone matrix, shoring our skeletal health. But this is not always the case, particularly if we are not obtaining enough Vitamin K2 as MK-7 from either our diets or supplementation.Vitamin K2 as MK-7 helps the body properly utilize calcium by activating vitamin K-dependent proteins already present in the body:• Osteocalcin, once activated by K2, binds calcium to the bone mineral matrix (where it is needed)• Matrix Gla Protein (MGP), once activated by K2, inhibits calcium from depositing in arteries and soft tissues (where it can cause harm)Yet this is just the tip of the iceberg. New research is coming to light connecting the already established Vitamin K2 as MK-7 mechanism to other areas of health, including brain, vision, and more. The Most Comprehensive Vitamin K2 OfferOnce Gnosis by Lesaffre acquired NattoPharma in 2021, the company could unequivocally state that it offered the most comprehensive Vitamin K2 portfolio on the market. It now offers customers, • MenaQ7® - the best clinically validated K2 as MK-7 on the market, as it was the source material used in more than 22 human clinical trials confirming safe and efficacious health benefits. Further, MenaQ7 is the only K2 as MK-7 patented for cardiovascular health.• vitaMK7® - naturally produced from a patented biofermentation process, the line has recently been enhanced by introducing the Matrix protective technology.

Vitamin K2 as MK-7
Details about NATTOPHARMA ASA
Frequently Asked Questions about Kate Quackenbush
Kate Quackenbush currently works for NATTOPHARMA ASA.
Kate Quackenbush's role at NATTOPHARMA ASA is Director of Communications.
Kate Quackenbush's email address is ***@nattopharma.com. To view Kate Quackenbush's full email address, please signup to ConnectPlex.
Kate Quackenbush works in the BioTech/Drugs industry.
Kate Quackenbush's colleagues at NATTOPHARMA ASA are , Rudi Man, William Sommer, Kathe Bleken, Eric Anderson, Erik Tjoerstad, Hind Aidem and others.
Kate Quackenbush's phone number is
See more information about Kate Quackenbush